| Bioactivity | JNJ-38877605-d1 (compound DO-2) is a highly selective MNNG HOS transforming (MET) inhibitor. JNJ-38877605-d1 is thought to diminish the formation of the Aldehyde Oxidase 1 inactive metabolite M3[1]. |
| Name | JNJ-38877605-d1 |
| CAS | 1936472-36-4 |
| Formula | C19H12DF2N7 |
| Molar Mass | 378.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sikkema BJ, et al. Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasma. J Pharm Biomed Anal. 2024 Jan 4;240:115962. |
JNJ-38877605-d1
CAS: 1936472-36-4 F: C19H12DF2N7 W: 378.36
JNJ-38877605-d1 (compound DO-2) is a highly selective MNNG HOS transforming (MET) inhibitor. JNJ-38877605-d1 is thought
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.